A Mechanistic Review on Toxicity Effects of Methamphetamine
Persistent methamphetamine use causes many toxic effects in various organs, including the brain, heart, liver, kidney and eyes. The extent of its toxicity depends on numerous pharmacological factors, including route of administration, dose, genetic polymorphism related to drug metabolism and polysub...
Published in: | International Journal of Medical Sciences |
---|---|
Main Author: | |
Format: | Review |
Language: | English |
Published: |
Ivyspring International Publisher
2025
|
Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85215677556&doi=10.7150%2fijms.99159&partnerID=40&md5=0c2d3074d5915b4bdc93aef8c7a364d1 |
id |
2-s2.0-85215677556 |
---|---|
spelling |
2-s2.0-85215677556 Ramli F.F.; Rejeki P.S.; ‘Izzah Ibrahim N.; Abdullayeva G.; Halim S. A Mechanistic Review on Toxicity Effects of Methamphetamine 2025 International Journal of Medical Sciences 22 3 10.7150/ijms.99159 https://www.scopus.com/inward/record.uri?eid=2-s2.0-85215677556&doi=10.7150%2fijms.99159&partnerID=40&md5=0c2d3074d5915b4bdc93aef8c7a364d1 Persistent methamphetamine use causes many toxic effects in various organs, including the brain, heart, liver, kidney and eyes. The extent of its toxicity depends on numerous pharmacological factors, including route of administration, dose, genetic polymorphism related to drug metabolism and polysubstance abuse. Several molecular pathways have been proposed to activate oxidative stress, inflammation and apoptosis: B-cell lymphoma protein 2 (Bcl-2)-associated X (Bax)/Bcl2/caspase-3, nuclear factor erythroid 2-related factor (Nrf2)/heme oxygenase-1 (HO-1), protein kinase B (Akt)/mammalian target of rapamycin (mTOR)/p70S6K, trace amine-associated receptor 1 (TAAR1)/cAMP/lysyl oxidase, Sigmar1/ cAMP response element-binding protein (CREB)/mitochondrial fission-1 protein (Fis1), NADPH-Oxidase-2 (NOX-2), renal autophagy pathway, vascular endothelial growth factor (VEGF)/phosphatidylinositol-3-kinase (PI3K)/ protein kinase B (Akt)/endothelial nitric oxide synthase (eNOS), Nupr1/Chop/P53/PUMA/Beclin1 and Toll-like receptor (TLR)4/MyD88/TRAF6 pathways. The activation promotes pathological changes, including the disruption of the blood-brain barrier, myocardial infarction, cardiomyopathy, acute liver failure, acute kidney injury, chronic kidney disease, keratitis, retinopathy and vision loss. This review revisits the pharmacological profiles of methamphetamine and its effects on the brain, heart, liver, eyes, kidneys and endothelium. Understanding the mechanisms of methamphetamine toxicity is essential in developing treatment strategies to reverse or attenuate the progress of methamphetamine-associated organ damage. © The author(s). Ivyspring International Publisher 14491907 English Review All Open Access; Gold Open Access |
author |
Ramli F.F.; Rejeki P.S.; ‘Izzah Ibrahim N.; Abdullayeva G.; Halim S. |
spellingShingle |
Ramli F.F.; Rejeki P.S.; ‘Izzah Ibrahim N.; Abdullayeva G.; Halim S. A Mechanistic Review on Toxicity Effects of Methamphetamine |
author_facet |
Ramli F.F.; Rejeki P.S.; ‘Izzah Ibrahim N.; Abdullayeva G.; Halim S. |
author_sort |
Ramli F.F.; Rejeki P.S.; ‘Izzah Ibrahim N.; Abdullayeva G.; Halim S. |
title |
A Mechanistic Review on Toxicity Effects of Methamphetamine |
title_short |
A Mechanistic Review on Toxicity Effects of Methamphetamine |
title_full |
A Mechanistic Review on Toxicity Effects of Methamphetamine |
title_fullStr |
A Mechanistic Review on Toxicity Effects of Methamphetamine |
title_full_unstemmed |
A Mechanistic Review on Toxicity Effects of Methamphetamine |
title_sort |
A Mechanistic Review on Toxicity Effects of Methamphetamine |
publishDate |
2025 |
container_title |
International Journal of Medical Sciences |
container_volume |
22 |
container_issue |
3 |
doi_str_mv |
10.7150/ijms.99159 |
url |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85215677556&doi=10.7150%2fijms.99159&partnerID=40&md5=0c2d3074d5915b4bdc93aef8c7a364d1 |
description |
Persistent methamphetamine use causes many toxic effects in various organs, including the brain, heart, liver, kidney and eyes. The extent of its toxicity depends on numerous pharmacological factors, including route of administration, dose, genetic polymorphism related to drug metabolism and polysubstance abuse. Several molecular pathways have been proposed to activate oxidative stress, inflammation and apoptosis: B-cell lymphoma protein 2 (Bcl-2)-associated X (Bax)/Bcl2/caspase-3, nuclear factor erythroid 2-related factor (Nrf2)/heme oxygenase-1 (HO-1), protein kinase B (Akt)/mammalian target of rapamycin (mTOR)/p70S6K, trace amine-associated receptor 1 (TAAR1)/cAMP/lysyl oxidase, Sigmar1/ cAMP response element-binding protein (CREB)/mitochondrial fission-1 protein (Fis1), NADPH-Oxidase-2 (NOX-2), renal autophagy pathway, vascular endothelial growth factor (VEGF)/phosphatidylinositol-3-kinase (PI3K)/ protein kinase B (Akt)/endothelial nitric oxide synthase (eNOS), Nupr1/Chop/P53/PUMA/Beclin1 and Toll-like receptor (TLR)4/MyD88/TRAF6 pathways. The activation promotes pathological changes, including the disruption of the blood-brain barrier, myocardial infarction, cardiomyopathy, acute liver failure, acute kidney injury, chronic kidney disease, keratitis, retinopathy and vision loss. This review revisits the pharmacological profiles of methamphetamine and its effects on the brain, heart, liver, eyes, kidneys and endothelium. Understanding the mechanisms of methamphetamine toxicity is essential in developing treatment strategies to reverse or attenuate the progress of methamphetamine-associated organ damage. © The author(s). |
publisher |
Ivyspring International Publisher |
issn |
14491907 |
language |
English |
format |
Review |
accesstype |
All Open Access; Gold Open Access |
record_format |
scopus |
collection |
Scopus |
_version_ |
1823296151919525888 |